Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9NQC3 (
Nogo
)
1,062
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
neurite outgrowth inhibitor
protein
Nogo
is one of 300 proteins that contain a reticulon homology domain, which is responsible for their association with the endoplasmic reticulum. Here we have found that the
Nogo-B
spliceform becomes phosphorylated at Ser107 in response to lipopolysaccharide in RAW264 macrophages or anisomycin in HeLa cells. The phosphorylation is prevented by SB 203580, an inhibitor of SAPK2a (stress-activated protein kinase 2a)/p38a and
SAPK2b
/
p38b
, and does not occur in embryonic fibroblasts generated from SAPK2a/p38a-deficient mice.
Nogo-B
is phosphorylated at Ser107 in vitro by MAPKAP-K2 [MAPK (mitogen-activated protein kinase)-activated protein kinase-2] or MAPKAP-K3, but not by other protein kinases that are known to be activated by SAPK2a/p38a. The anisomycin-induced phosphorylation of Ser107 in HeLa cells can be prevented by 'knockdown' of MAPKAP-K2 using siRNA (small interfering RNA). Taken together, our results identify
Nogo-B
as a new physiological substrate of MAPKAP-K2.
...
PMID:Nogo-B is a new physiological substrate for MAPKAP-K2. 1609 39